Non-invasive measurement of endothelial function via brachial flow-mediated dilatation provides a surrogate measure of coronary endothelial function.
Brachial FMD may enable non-invasive coronary endothelial assessment; leaves open its value for risk stratification or therapy guidance.
Endothelial dysfunction, due to reductions in nitric oxide (NO) action, is an early feature of macrovascular disease. 2. Non-invasive measurement of endothelial function may be assessed by postischaemic dilation of forearm vessels, using plethysmography, or flow-mediated dilatation of the brachial artery, using ultrasound. 3. Brachial flow-mediated dilatation reflects NO release and/or action more than forearm hyperaemia. 4. These techniques have been used as surrogate measures of coronary endothelial function. 5. Methodological, physiological and clinical aspects of the techniques are discussed.
No takes yet. Share an insight, caveat, or question.
Playford et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: